Daniel Herman, MD, PhD is an Assistant Professor in the Department of Pathology & Laboratory Medicine, where he is a practicing clinical pathologist and biomedical informatics researcher. Herman is a physician-scientist working at the intersection of data science, laboratory medicine, and clinical information systems. He directs one of the clinical chemistry laboratories at the Hospital of the University of Pennsylvania. His research group focuses on leveraging electronic health record data to improve screening for underdiagnosed diseases like primary aldosteronism. This includes training clinical prediction models, developing model-triggered decision support, and designing policy and oversight practices for ensuring that deployed clinical AI tools are safe and effective. Herman completed his MD and PhD degrees at Harvard Medical School and trained in clinical pathology at the University of Washington.
Senior Fellow
Daniel Herman, MD, PhD
- Assistant Professor, Pathology and Laboratory Medicine, Perelman School of Medicine
Related Content
Health Care Algorithms Can Improve or Worsen Racial and Ethnic Disparities
Users Need To Understand Existing Disparities and Why Race Can Be Imprecise
Exploring the Policies That Are Closing Rural Hospitals
A Penn LDI Virtual Seminar Looks at Trends Driving the Crisis
4 Ways Health Officials Can Communicate Better in the Next Pandemic
COVID-19’s Key Challenges Provide Insight for Future Outbreaks
Future Bundled Payment Models Need To Engage Physician Group Practices
Looking Forward, LDI Fellows Offer Their Perspectives and Expertise
Fixing Medicare’s Problem of Inadequately Coordinated Care
Penn LDI's Amol Navathe Testifies Before the U.S. Senate Committee on Finance
In The Media New York Times
Mental Health and Substance Use Disorders Often Go Untreated for Parents on Medicaid
Interview
Medicaid’s New Policy Boosts Street Medicine in the U.S.
But More Funding and Better Rules Are Needed to Help People Who Are Addicted or Homeless, LDI Experts Say
7 Ways to Improve an Already Effective Treatment for Stimulant Use Disorder
New Commentary Suggests Ways to Make Contingency Management More Effective For Drugs Like Cocaine and Methamphetamine
In The Media Los Angeles Times
‘Miracle’ Weight-Loss Drugs Could Have Reduced Health Disparities. Instead They Got Worse
Interview
Why Health Privacy Online Is a Myth
Google Knows More About Your Health Than Your Mom, LDI Experts Explain. And Here's What Can Be Done About It
How Can We Improve Telemedicine for Patients with Gynecologic Cancer?
Fewer Than 30% of Patients Used Telehealth Even During the Pandemic